adnkronos

Paradigm Therapeutics Acquires Late Stage “Breakthrough Therapy” Designated Therapy for Treatment of All Subtypes of Epidermolysis Bullosa (EB)

(Adnkronos) - 'Topical Therapy for Treating the Wounds and Lesions on the Entire Skin Surface' MT PLEASANT, S.C., Aug. 22, 2023...